189
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Effective photothermal chemotherapy with docetaxel-loaded gold nanospheres in advanced prostate cancer

, , , , , & show all
Pages 568-576 | Received 02 Dec 2014, Accepted 04 Feb 2015, Published online: 04 Mar 2015

References

  • Baade PD, Youlden DR, Krnjacki LJ. International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res 2009;53:171–84
  • Dimakakos A, Armakolas A, Koutsilieris M. Novel tools for prostate cancer prognosis, diagnosis, and follow-up. Biomed Res Int 2014;2014:890697
  • Chang AJ, Autio KA, Roach M III, Scher HI. High-risk prostate cancer-classification and therapy. Nat Rev Clin Oncol 2014;11:308–23
  • Bach C, Pisipati S, Daneshwar D, et al. The status of surgery in the management of high-risk prostate cancer. Nat Rev Urol 2014;11:342–51
  • McKeage K. Docetaxel: a review of its use for the first-line treatment of advanced castration-resistant prostate cancer. Drugs 2012;72:1559–77
  • Shah M, Badwaik VD, Dakshinamurthy R. Biological applications of gold nanoparticles. J Nanosci Nanotechnol 2014;14:344–62
  • Schwartzberg AM, Olson TY, Talley CE, Zhang JZ. Synthesis, characterization, and tunable optical properties of hollow gold nanospheres. J Phys Chem B 2006;110:19935–44
  • Bazak R, Houri M, El Achy S, et al. Cancer active targeting by nanoparticles: a comprehensive review of literature. J Cancer Res Clin Oncol 2014. [Epub ahead of print]. doi: 10.1007/s00432-014-1767-3
  • Jain S, Doshi AS, Iyer AK, Amiji MM. Multifunctional nanoparticles for targeting cancer and inflammatory diseases. J Drug Target 2013;21:888–903
  • Sultana S, Khan MR, Kumar M, et al. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review. J Drug Target 2013;21:107–25
  • Chen J, Zhu S, Tong L, et al. Superparamagnetic iron oxide nanoparticles mediated (131)I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude mice. BMC Cancer 2014;14:114
  • Zhao P, Astruc D. Docetaxel nanotechnology in anticancer therapy. ChemMedChem 2012;7:952–72
  • Jiao PF, Zhou HY, Chen LX, Yan B. Cancer-targeting multifunctionalized gold nanoparticles in imaging and therapy. Curr Med Chem 2011;18:2086–102
  • Sanna V, Sechi M. Nanoparticle therapeutics for prostate cancer treatment. Nanomedicine 2012;1:S31–6
  • Wang M, Thanou M. Targeting nanoparticles to cancer. Pharmacol Res 2010;62:90–9
  • Barve A, Jin W, Cheng K. Prostate cancer relevant antigens and enzymes for targeted drug delivery. J Control Release 2014;187:118–32
  • Morosini V, Bastogne T, Frochot C, et al. Quantum dot-folic acid conjugates as potential photosensitizers in photodynamic therapy of cancer. Photochem Photobiol Sci 2011;10:842–51
  • Yao V, Berkman CE, Choi JK, et al. Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acid. Prostate 2010;70:305–16
  • Yao V, Parwani A, Maier C, et al. Moderate expression of prostate-specific membrane antigen, a tissue differentiation antigen and folate hydrolase, facilitates prostate carcinogenesis. Cancer Res 2008;68:9070–7
  • Bahl A, Masson S, Birtle A, et al. Second-line treatment options in metastatic castration-resistant prostate cancer: a comparison of key trials with recently approved agents. Cancer Treat Rev 2014;40:170–7
  • Ganju A, Yallapu MM, Khan S, et al. Nanoways to overcome docetaxel resistance in prostate cancer. Drug Resist Updat 2014;17:13–23
  • Elliott RL. Combination cancer immunotherapy Expanding Paul Ehrlich's Magic Bullet Concept. Surg Oncol 2012;21:53–5
  • Hu CM, Zhang L. Therapeutic nanoparticles to combat cancer drug resistance. Curr Drug Metab 2009;10:836–41

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.